You have probably seen the generic break-even projections that come with any capital equipment pitch.
A chart, some optimistic numbers, and a statement that sounds something like "most practices see payoff within X months."
Those projections are fine as a starting point, but they tend to treat every practice as if it is the same. And yours is not.
The reality is that the payoff timeline for the PiezoWave2T varies meaningfully based on what kind of practice you are running, where you are in your growth trajectory, and how you integrate the technology into your patient workflow.
That is not a weakness in the case of investment. It is the reason the case is so strong, because even in the slowest realistic scenario, you are looking at a payoff well inside two years. And in the most common scenarios, it is dramatically faster than that.
Rather than rehashing a simple formula, let us look at what drives the payoff timeline and how different practice profiles experience it.
If you are already running a busy practice with a solid patient base, your payoff timeline is going to be the shortest. This is not because you already have the single most expensive thing to acquire in healthcare: patients who trust you.
When you introduce MyACT to an established patient base, you are not starting from zero on awareness or demand. You have patients currently in your care who have conditions that respond to acoustic wave therapy and already trust your clinical judgment. When you recommend a treatment protocol, they are far more likely to say yes than a cold lead who walked in off the street.
Practices in this category routinely build to 15 to 25 MyACT treatments per week within the first 60 to 90 days simply by having conversations with their existing patients during regular visits. At that volume, even at moderate pricing, payoff can happen in as little as three to four months. The device essentially pays for itself during the initial ramp-up period.
Then there is the practice that is past the startup phase but not yet at full maturity. Maybe you have been open for three to five years. Your patient base is growing but not yet at the volume where you feel comfortable. You are investing in marketing, building referral relationships, and working to establish your reputation in the community.
For this practice type, the PiezoWave2T does double duty.
It generates direct treatment revenue on its own merits, but it also serves as a marketing differentiator that accelerates your broader growth trajectory. You are no longer just another chiropractic office competing for the same pool of patients. You are the practice in your area offering advanced acoustic wave therapy, which gives your marketing something concrete to say and gives potential patients a specific reason to choose you.
The payoff timeline here typically runs six to ten months. The treatment revenue takes a bit longer to build because your patient base is smaller, but the marketing lift and new patient acquisition that the PiezoWave2T enables often more than compensates.
Many practices in this growth phase report that the device accelerated their overall practice growth beyond what their pre-purchase projections anticipated.
Opening a new practice is one of the most financially stressful things a healthcare provider can do. Every dollar matters, every piece of equipment needs to justify itself quickly, and there is very little room for investments that take years to show a return.
Conventional wisdom might say that a startup practice should wait until it is established before making a capital equipment investment like the PiezoWave2T.
Yet, there is a counterargument worth considering: practices that launch with differentiated offerings from day one tend to build their patient base faster than practices that look identical to everyone else in the market.
For a startup, the payoff timeline is realistically in the 10-to-18-month range because you are simultaneously building a patient base while introducing the modality. But there is a compounding effect that pure payoff math does not capture. Every patient who comes to you specifically because you offer MyACT is a patient who might not have found you otherwise. Every positive outcome from those treatments generates a review or referral that helps build your practice's reputation.
The PiezoWave2T in a startup practice is not just a revenue generator. It is a practice builder. The payoff period is longer, but the total impact on the practice's growth trajectory can be significant.
Practices with multiple providers or multiple locations have a different calculus entirely. The device cost is the same, but the potential treatment volume is substantially higher because you have more providers who can prescribe MyACT protocols and more patient touchpoints where the treatment can be recommended.
A two-provider practice can realistically generate twice the treatment volume of a solo practice with the same device, especially when MyACT sessions are delivered by trained staff rather than the providers themselves. In a multi-location scenario, the math becomes even more interesting if you rotate the device between locations during the initial phase or stagger device purchases as each location proves the model.
Multi-provider practices frequently see payoff in the three-to-six-month range because the treatment volume ramps up so quickly. The device is simply seeing more patients per week than it would in a solo practice, and the math responds accordingly.
Understanding what accelerates the timeline is useful, but it is equally valuable to understand what slows it down, because most of the common delays are entirely within your control.
The number one factor that extends the payoff period is not pricing, market conditions, or patient demographics. It is underutilization driven by poor integration into the practice workflow.
Practices that buy the PiezoWave2T, put it in a treatment room, and then wait for patients to ask about it will always have a longer payoff timeline than practices that proactively build it into their clinical conversations and treatment planning.
The second factor is pricing timidity.
Some practices, especially in smaller markets, set their treatment price below what the market would support because they are nervous about patient pushback. In most markets, patients who understand the value of the treatment and who are experiencing results are not particularly price-sensitive about a $75 to $150 per session fee. Underpricing to avoid an objection that rarely comes just extends your payoff timeline unnecessarily.
The third factor is failing to train staff on both the clinical delivery and the patient communication around MyACT.
When your front desk cannot confidently explain what the treatment is and your therapy tech is not comfortable delivering it, fewer patients get scheduled and fewer treatments get delivered. Investing in staff training during the first 30 days dramatically improves ramp-up speed.
Four to eighteen months is a wide window, and that is intentional. Your specific practice will land somewhere in that range based on the factors we have discussed: existing patient volume, integration effort, pricing strategy, staff engagement, and market dynamics.
The important insight is that even the longest realistic scenario, 18 months, is exceptionally fast by healthcare capital equipment standards. And the most common scenario for an established practice doing the basics well is payoff inside six months.
In either case, what follows the payoff period is years of profitable utilization with minimal ongoing costs.
To understand where your specific practice would likely fall on that timeline, give us a call at 1-770-295-0049 or drop a line to info@elvationusa.com. We can walk through a payoff model using your actual patient volume, market pricing, and practice structure.